Nitric oxide‐cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea‐pig in vitro
- 1 September 2001
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 535 (2), 507-518
- https://doi.org/10.1111/j.1469-7793.2001.00507.x
Abstract
1. We tested the hypothesis that nitric oxide (NO) augments vagal neurotransmission and bradycardia via phosphorylation of presynaptic calcium channels to increase vesicular release of acetylcholine. 2. The effects of enzyme inhibitors and calcium channel blockers on the actions of the NO donor sodium nitroprusside (SNP) were evaluated in isolated guinea-pig atrial-right vagal nerve preparations. 3. SNP (10 microM) augmented the heart rate response to vagal nerve stimulation but not to the acetylcholine analogue carbamylcholine (100 nM). SNP also increased the release of [3H]acetylcholine in response to field stimulation. No effect of SNP was observed on either the release of [3H] acetylcholine or the HR response to vagal nerve stimulation in the presence of the guanylyl cyclase inhibitor 1H-(1,2,4)-oxadiazolo-(4,3-a)-quinoxalin-1-one (ODQ, 10 microM). 4. The phosphodiesterase 3 (PDE 3) inhibitor milrinone (1 microM) increased the release of [3H] acetylcholine and the vagal bradycardia and prevented any further increase by SNP. SNP was still able to augment the vagal bradycardia in the presence of the protein kinase G inhibitor KT5823 (1 microM) but not after protein kinase A (PKA) inhibition with H-89 (0.5 microM) or KT5720 (1 microM) had reduced the HR response to vagal nerve stimulation. Neither milrinone nor H-89 changed the HR response to carbamylcholine. 5. SNP had no effect on the magnitude of the vagal bradycardia after inhibition of N-type calcium channels with omega-conotoxin GVIA (100 nM). 6. These results suggests that NO acts presynaptically to facilitate vagal neurotransmission via a cGMP-PDE 3-dependent pathway leading to an increase in cAMP-PKA-dependent phosphorylation of presynaptic N-type calcium channels. This pathway may augment the HR response to vagal nerve stimulation by increasing presynaptic calcium influx and vesicular release of acetylcholine.Keywords
This publication has 50 references indexed in Scilit:
- Role of cGMP-inhibited Phosphodiesterase and Sarcoplasmic Calcium in Mediating the Increase in Basal Heart Rate with Nitric Oxide DonorsJournal of Molecular and Cellular Cardiology, 2000
- Adrenergic inhibition of endogenous acetylcholine release on postganglionic cardiac vagal nerve terminalsCardiovascular Research, 2000
- Heart-Rate Recovery Immediately after Exercise as a Predictor of MortalityNew England Journal of Medicine, 1999
- Effect of nitric oxide synthase inhibition on the sympatho-vagal control of heart rateJournal of the Autonomic Nervous System, 1998
- Role of the NO-cGMP pathway in the muscarinic regulation of the L-type Ca2+current in human atrial myocytesThe Journal of Physiology, 1998
- Muscarinic autoinhibition of acetylcholine release in mouse atria is not transduced through cyclic AMP or protein kinase CJournal of Autonomic Pharmacology, 1996
- A Novel Peptide from Funnel Web Spider Venom, ω-Aga-TK, Selectively Blocks P-Type Calcium ChannelsBiochemical and Biophysical Research Communications, 1993
- Pharmacologic responses and spectral analyses of spontaneous fluctuations in heart rate and blood pressure in SHR ratsJournal of the Autonomic Nervous System, 1991
- K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinasesBiochemical and Biophysical Research Communications, 1986
- A venom peptide with a novel presynaptic blocking actionNature, 1984